Suzhou Kemai Biosynthesis Co., Ltd. is a technology-driven enterprise specializing in the field of synthetic biology. Leveraging cutting-edge synthetic biology technologies such as gene editing, synthetic genomes, and metabolic engineering, the company develops innovative products including new biomaterials, pharmaceuticals, and biofuels.
Our team members come from prestigious universities including Peking University, Sichuan University, and Nanjing University of Industrial Technology, bringing together cross-disciplinary expertise in genetic engineering, enzyme engineering, structural biology, and other fields. We provide * and sustainable solutions to global research institutions, pharmaceutical companies, and industrial partners. The company actively participates in international cooperation projects and has established partnerships with research institutes and Fortune Global 500 companies, jointly advancing innovation in the field of synthetic biology. Beyond technological innovation, we place great importance on talent development, promoting public understanding and participation in the advancement of synthetic biology through science popularization, education, and training initiatives.
Looking ahead, the company will continue to uphold the principles of scientific rigor and relentless innovation, striving to become a leading player in the field of synthetic biology. We are committed to fostering the prosperity and progress of global biotechnology and contributing enduringly to the future development of science and industry.Companies
